Best of Oncology™ 2026, Albuquerque
Venue: Sheraton Albuquerque Airport Hotel, 2910 Yale Boulevard Southeast, Albuquerque, NM, United States
Official conference page for Best of Oncology™ 2026, Albuquerque. https://binaytara.org/projects/conferences/best-of-oncology-albuquerque
Faculty disclosures
Identification and mitigation of potential conflicts of interest
All conflict of interest has been identified and mitigated for individuals in control of contents.
Planning committee disclosure statement
None of the members of the planning committee, nor any member of their immediate families, have a relevant financial interest in or affiliation with any commercial supporter of this educational activity and/or with the manufacturer(s) of commercial products and/or providers of any commercial services discussed in this educational activity.
Conference Director
Awaiting faculty disclosure.
Conference Co-Chair
Awaiting faculty disclosure.
Planning Committee
Awaiting faculty disclosure.
Session Chairs
has a financial relationship (Other) with Astra Zeneca.
has a financial relationship (Advisor) with Curio Science; financial relationship (Advisor) with Bristol Myers Squib; financial relationship (Advisor) with Johnson and Johnson.
No, I have not had a financial relationship with an ineligible company within the past 24 months.
Awaiting faculty disclosure.
Topic Presenters
Awaiting faculty disclosure.
Awaiting faculty disclosure.
Awaiting faculty disclosure.
Awaiting faculty disclosure.
Awaiting faculty disclosure.
Awaiting faculty disclosure.
No, I have not had a financial relationship with an ineligible company within the past 24 months.
Awaiting faculty disclosure.
Awaiting faculty disclosure.
has a financial relationship (Researcher) with Arcus Biosciences; financial relationship (Advisor) with Astellas; financial relationship (Researcher) with BMS; financial relationship (Advisor) with Corcept Therapeutics; financial relationship (Researcher) with Crystal Genomics; financial relationship (Speaker) with Fibrogen (in-house company lecture); financial relationship (Advisor) with Gilead; financial relationship (Consultant) with Grail; financial relationship (Advisor) with Jazz Pharmaceuticals; financial relationship (Advisor) with Legend Biotech; financial relationship (Advisor) with Merus; financial relationship (Researcher) with Novartis; financial relationship (Speaker) with Pfizer (in-house company lecture); financial relationship (Speaker) with Renovo (in-house compnay lecture); financial relationship (Researcher) with Revolution Medicines; financial relationship (Advisor) with Revolution Medicines; financial relationship (Speaker) with Revolution Medicines (in-house company speaker); financial relationship (Researcher) with Roche/Genentech; financial relationship (Advisor) with Tango Therapeutics; financial relationship (Researcher) with Verastem.
Awaiting faculty disclosure.
Awaiting faculty disclosure.
Awaiting faculty disclosure.
Awaiting faculty disclosure.
Awaiting faculty disclosure.
Awaiting faculty disclosure.
Case Presenters
Awaiting faculty disclosure.
has a financial relationship (Speaker) with bristol myers squibb.
Awaiting faculty disclosure.
Awaiting faculty disclosure.
Awaiting faculty disclosure.
Awaiting faculty disclosure.
Awaiting faculty disclosure.
Panelists
Awaiting faculty disclosure.
Awaiting faculty disclosure.
Awaiting faculty disclosure.
Awaiting faculty disclosure.